Stephen Donahue

1.4k total citations
31 papers, 1.1k citations indexed

About

Stephen Donahue is a scholar working on Surgery, Molecular Biology and Economics and Econometrics. According to data from OpenAlex, Stephen Donahue has authored 31 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Surgery, 9 papers in Molecular Biology and 8 papers in Economics and Econometrics. Recurrent topics in Stephen Donahue's work include Lipoproteins and Cardiovascular Health (10 papers), Pharmaceutical Economics and Policy (7 papers) and Health Systems, Economic Evaluations, Quality of Life (5 papers). Stephen Donahue is often cited by papers focused on Lipoproteins and Cardiovascular Health (10 papers), Pharmaceutical Economics and Policy (7 papers) and Health Systems, Economic Evaluations, Quality of Life (5 papers). Stephen Donahue collaborates with scholars based in United States, France and Germany. Stephen Donahue's co-authors include Corinne Hanotin, Daniel Gaudet, Harold Bays, Jennifer G. Robinson, Yunling Du, Helen M. Colhoun, Robert Weiss, Jian Zhao, Ioanna Gouni‐Berthold and Gerald F. Watts and has published in prestigious journals such as Nature Communications, Gastroenterology and Journal of the American College of Cardiology.

In The Last Decade

Stephen Donahue

30 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Stephen Donahue United States 14 583 281 181 166 142 31 1.1k
Michael Igel Germany 13 883 1.5× 94 0.3× 239 1.3× 245 1.5× 284 2.0× 18 1.5k
Richard McLain United States 16 488 0.8× 177 0.6× 99 0.5× 188 1.1× 179 1.3× 25 930
Maurice G. Emery United States 16 469 0.8× 175 0.6× 44 0.2× 191 1.2× 160 1.1× 50 1.0k
Neil Hounslow United Kingdom 16 604 1.0× 167 0.6× 50 0.3× 305 1.8× 106 0.7× 35 858
Jong-Soon Park United States 12 793 1.4× 171 0.6× 93 0.5× 632 3.8× 198 1.4× 27 1.7k
Kathryn A. Krueger United States 17 568 1.0× 86 0.3× 125 0.7× 574 3.5× 202 1.4× 29 1.7k
David Neff United States 17 938 1.6× 299 1.1× 51 0.3× 394 2.4× 198 1.4× 39 1.4k
Emil M. deGoma United States 19 667 1.1× 102 0.4× 102 0.6× 425 2.6× 206 1.5× 40 1.4k
Michael Stepanavage United States 11 905 1.6× 167 0.6× 72 0.4× 540 3.3× 81 0.6× 16 1.3k
Jemma C. Hopewell United Kingdom 22 766 1.3× 112 0.4× 128 0.7× 420 2.5× 314 2.2× 58 1.8k

Countries citing papers authored by Stephen Donahue

Since Specialization
Citations

This map shows the geographic impact of Stephen Donahue's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen Donahue with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen Donahue more than expected).

Fields of papers citing papers by Stephen Donahue

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephen Donahue. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen Donahue. The network helps show where Stephen Donahue may publish in the future.

Co-authorship network of co-authors of Stephen Donahue

This figure shows the co-authorship network connecting the top 25 collaborators of Stephen Donahue. A scholar is included among the top collaborators of Stephen Donahue based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stephen Donahue. Stephen Donahue is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Trotter, Dinko González, Stephen Donahue, Chris Wynne, et al.. (2025). GDF8 and activin A are the key negative regulators of muscle mass in postmenopausal females: a randomized phase I trial. Nature Communications. 16(1). 4376–4376. 2 indexed citations
2.
Blom, Dirk, Mariko Harada‐Shiba, Paolo Rubba, et al.. (2020). Efficacy and Safety of Alirocumab in Adults With Homozygous Familial Hypercholesterolemia. Journal of the American College of Cardiology. 76(2). 131–142. 119 indexed citations
3.
Krempf, Michel, Paul N. Hopkins, Éric Bruckert, Shane Lee, & Stephen Donahue. (2019). Efficacy and Safety of Alirocumab in Patients With Autosomal Dominant Hypercholesterolemia Associated With Proprotein Convertase Subtilisin/Kexin Type 9 Gain-of-Function or Apolipoprotein B Loss-of-Function Mutations. The American Journal of Cardiology. 125(6). 880–886. 4 indexed citations
4.
Vellas, Bruno, Roger A. Fielding, Roberto Bernabei, et al.. (2018). Implications of ICD-10 for Sarcopenia Clinical Practice and Clinical Trials: Report by the International Conference on Frailty and Sarcopenia Research Task Force. The Journal of Frailty & Aging. 7(1). 2–9. 128 indexed citations
5.
6.
Bays, Harold, Daniel Gaudet, Robert Weiss, et al.. (2015). Alirocumab as Add-On to Atorvastatin Versus Other Lipid Treatment Strategies: ODYSSEY OPTIONS I Randomized Trial. The Journal of Clinical Endocrinology & Metabolism. 100(8). 3140–3148. 182 indexed citations
7.
Bays, Harold, Daniel Gaudet, Robert Weiss, et al.. (2014). Abstract 16194: PCSK9 Inhibitor Alirocumab as Add-on to Atorvastatin versus Other Lipid Treatment Strategies in Patients at High CVD Risk: ODYSSEY OPTIONS I. 130. 1 indexed citations
8.
Byrnes, John, et al.. (2009). Effects of the ACE2 inhibitor GL1001 on acute dextran sodium sulfate-induced colitis in mice. Inflammation Research. 58(11). 819–827. 54 indexed citations
9.
Rickels, Karl, Sanjay J. Mathew, Michael Banov, et al.. (2008). Effects of PRX-00023, a Novel, Selective Serotonin 1A Receptor Agonist on Measures of Anxiety and Depression in Generalized Anxiety Disorder. Journal of Clinical Psychopharmacology. 28(2). 235–239. 18 indexed citations
10.
Mathew, Sanjay J., et al.. (2008). Short-term tolerability of a nonazapirone selective serotonin 1A agonist in adults with generalized anxiety disorder: A 28-day, open-label study. Clinical Therapeutics. 30(9). 1658–1666. 5 indexed citations
11.
Reinhard, John F., et al.. (2007). Tolerability, Pharmacokinetics, and Neuroendocrine Effects of PRX‐00023, a Novel 5‐HT1A Agonist, in Healthy Subjects. The Journal of Clinical Pharmacology. 47(7). 817–824. 10 indexed citations
12.
Tay, Lee K., et al.. (2004). Simulation of the Impact of Atropisomer Interconversion on Plasma Exposure of Atropisomers of an Endothelin Receptor Antagonist. The Journal of Clinical Pharmacology. 44(7). 680–688. 21 indexed citations
13.
Bays, Harold, Leiv Ose, Neil J. Fraser, et al.. (2004). 1084-179 Ezetimibe/Simvastatin therapy is more effective than simvastatin alone at reducing remnant-like particle cholesterol. Journal of the American College of Cardiology. 43(5). A481–A481. 1 indexed citations
14.
Bjornsson, Thorir D., John A. Wagner, Stephen Donahue, et al.. (2003). A Review and Assessment of Potential Sources of Ethnic Differences in Drug Responsiveness. The Journal of Clinical Pharmacology. 43(9). 943–967. 115 indexed citations
15.
16.
Trapnell, Carol Braun, Stephen Donahue, Jerry M. Collins, et al.. (1998). Thalidomide does not alter the pharmacokinetics of ethinyl estradiol and norethindrone*. Clinical Pharmacology & Therapeutics. 64(6). 597–602. 22 indexed citations
17.
Donahue, Stephen, Jerry M. Collins, D. A. Flockhart, D. R. Abernethy, & Carol Braun Trapnell. (1997). Thalidomide pharmacokinetics do not change with chronic administration. Clinical Pharmacology & Therapeutics. 61(2). 3 indexed citations
18.
Donahue, Stephen, et al.. (1997). Ticlopidine inhibition of phenytoin metabolism mediated by potent inhibition of CYP2C19*. Clinical Pharmacology & Therapeutics. 62(5). 572–577. 56 indexed citations
19.
Schwarting, Gerald A., Arthur S. Tischler, & Stephen Donahue. (1990). Fucosylation of Glycolipids in PC12 Cells Is Dependent on the Sequence of Nerve Growth Factor Treatment and Adenylate Cyclase Activation. Developmental Neuroscience. 12(3). 159–171. 10 indexed citations
20.
Donahue, Stephen, et al.. (1971). Counseling: Another Dimension in the Agent's Role.. TigerPrints (Clemson University). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Michael Igel Breakdown of academic impact, for papers by Richard McLain Breakdown of academic impact, for papers by Maurice G. Emery Breakdown of academic impact, for papers by Neil Hounslow Breakdown of academic impact, for papers by Jong-Soon Park Breakdown of academic impact, for papers by Kathryn A. Krueger Breakdown of academic impact, for papers by David Neff Breakdown of academic impact, for papers by Emil M. deGoma Breakdown of academic impact, for papers by Michael Stepanavage Breakdown of academic impact, for papers by Jemma C. Hopewell
Rankless by CCL
2026